This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The drug product development journey is long and, many times, quite expensive. Finding time and cost saving strategies is dependent on the development of the commercialization partners engagement. The Cambrex team believes that having the end in mind facilitates the most efficient method in bringing molecules from formulation to commercialization. While phase appropriate, fit-for-purpose formulation strategies are plentiful for Phase I, when positive clinical results are obtained and proof-of-concept is achieved, the ability to pivot to a commercial-ready formulation is key.
The strategies utilized to assist clients with faster and less costly solutions are predicated on engaging experts that have worked on Development to Commercialization projects. Understanding the commercial challenges and bringing practical solutions early in the formulation process and partnering with a broad team that can appropriately scale and execute on your drug product is critical.
This webinar will address these commercial challenges and offer suggestions for introducing practical solutions early in the formulation process.
Peppino De Agostinis
Director of Technical Services
Peppino has over 23 years of experience in the pharmaceutical industry. He spent the first years of his career in product development participating in multiple ANDA filing. Within product development, responsible for the site technical transfer, Peppino participated in numerous successful site transfers from sending to receiving units. Peppino has strong skills in technical transfer, manufacturing process improvement, and process validation.
Senior Director of Pharmaceutics and Formulation
Sarah brings more than 12 years of industrial experience, spanning both early and late phase drug development within innovator and CDMO pharma. Prior to joining Cambrex, she held positions at SSCI, GlaxoSmithKline, and Avista Pharma Solutions. Throughout her career, Sarah has authored several scientific publications and holds various patents. Her expertise in both solid-state chemistry and formulation development allows her to provide broad CMC expertise and efficient drug development activities for her clients. Sarah received her bachelor’s degree from Drake University and PhD from the University of Michigan in pharmaceutical sciences.
Director, Product Development
Satish Shetty is the Director of Product Development at Cambrex, Whippany. He has been with the company for 11 years. Prior to joining Halopharma and Cambrex, Satish worked for Barr Laboratories, Warner Lambert, Pfizer and Trigen Laboratories. He has a Masters degree in Pharmacy and an MBA from Washington State University. Satish is also a registered Pharmacist in New Jersey.
Editor, Custom Content
Informa Pharma Intelligence
Complete the form to register for our webinar!